SPHAERO
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
FR
EN
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
HN
Helen Byomire Ndagije
Publications (9)
Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study
Article scientifique · 2025
Evaluating the glycemic effects of Dolutegravir and its predictors among HIV patients in Uganda: A prospective cohort study
Article scientifique · 2024
The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda
Article scientifique · 2023
Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study
Article scientifique · 2022
Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study
Article scientifique · 2021
Dolutegravir-Based ART: Exploring Patient Safety and Acceptability Following National Roll-Out in Uganda
Article scientifique · 2021
Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting
Article scientifique · 2020
Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting
Article scientifique · 2020
Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
Article scientifique · 2020
Domaines principaux
Sciences de la santé
9
Statistiques
Consultations
25
Téléchargements
0
Votre avis compte
Une suggestion, un bug, un ressenti sur SPHAERO ? Une minute suffit.
Plus tard
Donner mon avis
Votre avis compte
Nom
(optionnel)
Courriel
(optionnel)
Type de retour
Suggestion
Avis général
Signaler un bug
Message
Annuler
Envoyer
Merci, votre message a bien été envoyé.